Investors Research Corp’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5K Buy
+124
New +$25.8K 0.01% 439
2022
Q3
Sell
-1,096
Closed -$57K 1093
2022
Q2
$57K Hold
1,096
0.02% 485
2022
Q1
$62K Hold
1,096
0.02% 487
2021
Q4
$56K Hold
1,096
0.02% 505
2021
Q3
$54K Hold
1,096
0.02% 508
2021
Q2
$63K Hold
1,096
0.02% 478
2021
Q1
$67K Hold
1,096
0.03% 461
2020
Q4
$59K Hold
1,096
0.02% 505
2020
Q3
$51K Hold
1,096
0.02% 502
2020
Q2
$57K Hold
1,096
0.03% 459
2020
Q1
$53K Hold
1,096
0.03% 432
2019
Q4
$55K Hold
1,096
0.03% 505
2019
Q3
$52K Hold
1,096
0.03% 504
2019
Q2
$52K Hold
1,096
0.03% 497
2019
Q1
$53K Buy
+1,096
New +$54.9K 0.03% 498

Other funds holding CAH

Investors Research Corp's CAH Position: Q2 2026 in Review

Investors Research Corp opened a new position in Cardinal Health (CAH) in Q2 2026: 124 shares worth $29.5K. The stake represents 0.01% of the portfolio and ranks #439 among its holdings. This is a return to the name: Investors Research Corp previously reported a position in CAH as recently as Q2 2022.

Investors Research Corp first reported a position in CAH in Q1 2019 and has held it in 15 quarters since. The position peaked at $67K in Q1 2021. 195 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Investors Research Corp held 124 shares of Cardinal Health worth $29.5K as of Q2 2026.
  • Cardinal Health was a new Investors Research Corp position in Q2 2026.
  • Cardinal Health made up 0.01% of Investors Research Corp's portfolio in Q2 2026, its #439 holding.
  • Investors Research Corp first reported a position in Cardinal Health in Q1 2019 and has held it in 15 quarters since.
  • Investors Research Corp's Cardinal Health position peaked at $67K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.